Association between intraoperative phenylephrine administration and umbilical artery pH in women with hypertensive disorders of pregnancy: a retrospective cohort study
In healthy pregnant women undergoing Cesarean section, treatment of post-spinal hypotension (PSH) with phenylephrine is reportedly more efficacious than ephedrine in preventing a decline in umbilical artery pH (UApH), which is an indicator of fetal acidosis. However, phenylephrine has the potential to reduce placental blood flow and consequently decrease UApH in women who develop hypertensive disorders of pregnancy (HDP), due to decreased cardiac function and placental vascular abnormalities. We aimed to verify the association between decreased UApH and phenylephrine administered before delivery to treat PSH in women with HDP.
This single-center retrospective cohort study was conducted between April 2008 and October 2016 by assessing the records of pregnant women with confirmed or suspected HDP who underwent Cesarean section under spinal anesthesia. The association between phenylephrine and the primary endpoint of decreased UApH was investigated using logistic regression analysis and propensity score matching.
In the original cohort of 107 pregnant women with HDP, neither univariate nor multivariate analysis indicated a significant association between phenylephrine treatment and decreased UApH [crude odds ratio (OR) = 2.26; 95% confidence interval (CI) 0.75–6.77; P = 0.14], (adjusted OR = 1.80; 95% CI 0.55–5.93; P = 0.33). Thirty patients each who were not treated with phenylephrine (control group) and were treated with phenylephrine (phenylephrine group) were matched by propensity score analysis. UApH [median (interquartile range)] was not significantly different between control and phenylephrine groups [7.30 (7.25–7.35) vs. 7.27 (7.25–7.30); P = 0.14].
Intraoperative phenylephrine administration to treat PSH in women with HDP was not associated with decreased UApH.
KeywordsHypertensive disorders of pregnancy Phenylephrine Post-spinal hypotension Cesarean section
This study was supported by our departmental funds.
Compliance with ethical standards
Conflict of interest
All authors have no conflicts of interest.
- 1.Cyna AM, Andrew M, Emmett RS, Middleton P, Simmons SW. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. 2006;4:CD002251.Google Scholar
- 17.Higgins N, Fitzgerald PC, van Dyk D, Dyer RA, Ridriguez N, McCarthy RJ, Wong CA. The effect ofprophylactic phenylephrine and ephedrine infusions on umbilical artery blood pH in women with preeclampsiaundergoing cesarean delivery with spinal anesthesia: a randomized, double-blind trial. Anesth Analg. 2018;126:1999–2006.CrossRefGoogle Scholar
- 19.Dyer RA, Emmanuel A, Adams SC, Lombard CJ, Arcache MJ, Vorster A, Wong CA, Higgins N, Reed AR, James MF, Joolay Y, Schulein S. van Dyk D. A randomised comparison of bolus phenylephrine and ephedrine for the management of spinal hypotension in patients with severe preeclampsia and fetal compromise. Int J Obstet Anesth. 2018;33:23–31.CrossRefGoogle Scholar
- 23.Dyer RA, Daniels A, Vorster A, Emmanuel A, Arcache MJ, Schulein S, Reed AR, Lombard CJ, James MF, van Dyk D. Maternal cardiac output response to colloid preload and vasopressor therapy during spinal anaesthesia for caesarean section in patients with severe pre-eclampsia: a randomised, controlled trial. Anaesthesia. 2018;73:23–31.CrossRefGoogle Scholar